{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:03:09Z","timestamp":1791514989899,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Somatostatin receptors (SSTRs) are G protein-coupled transmembrane receptors that serve as a specific molecular target for a number of radiopharmaceuticals utilized for the imaging of neuroendocrine tumors (NETs). <jats:sup>68<\/jats:sup>Ga-DOTA-TATE is a somatostatin analog that demonstrates a high affinity for SSTR2. Pediatric malignancies, such as neuroblastoma, pheochromocytoma, and paraganglioma, have been shown to express SSTR2, and <jats:sup>68<\/jats:sup>Ga-DOTA-TATE is currently being used to evaluate these pediatric neoplasms. We aimed to analyze the distribution pattern of <jats:sup>68<\/jats:sup>Ga-DOTA-TATE based on age and location in pediatric patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively analyzed 247 consecutive <jats:sup>68<\/jats:sup>Ga-DOTA-TATE whole-body PET\/CT scans performed in our department from May 2015 to April 2024 in pediatric patients with known or suspected neuroblastoma, neuroendocrine malignancy, pheochromocytoma, and paraganglioma. 93 subjects were included in this study who were disease-free at the time of imaging and had no tracer-avid lesion on <jats:sup>68<\/jats:sup>Ga-DOTA-TATE PET\/CT. The patients were divided into four groups according to age: infant (0\u20132\u00a0years), pre-school (3\u20136\u00a0years), school (7\u201312\u00a0years), and adolescent (13\u201318\u00a0years). A comparison of the SUV values of each organ across age groups was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The highest levels of physiological uptake were observed in the spleen across all age groups, except for infants, who demonstrated the highest SUV values in the kidneys. <jats:sup>68<\/jats:sup>Ga-DOTA-TATE uptake in the parotid glands, submandibular glands, thyroid gland, thymus, liver, spleen, adrenal glands, stomach, intestines, uterus, prostate, and testes demonstrated a statistically significant increase in the adolescent age group. In contrast to all internal organs, the lowest SUV max values were observed for all growth plates within the adolescent age group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study presents the bio-distribution pattern of <jats:sup>68<\/jats:sup>Ga-DOTA-TATE in pediatric patients, according to age and location. The ranges of the SUVmax and SUVmean values of <jats:sup>68<\/jats:sup>Ga-DOTA-TATE obtained in the various organs are of paramount importance for accurately diagnosing malignancy in <jats:sup>68<\/jats:sup>Ga-DOTA-TATE PET\/CT studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12149-025-02040-9","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:13:05Z","timestamp":1742357585000},"page":"650-662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Physiological bio-distribution of 68Ga-DOTA-TATE in pediatric patients"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-9752","authenticated-orcid":false,"given":"Nuh","family":"Filizoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Ozguven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Kesim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevser","family":"Oksuzoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Cagl\u0131yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunc","family":"Ones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuat","family":"Dede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil Turgut","family":"Turoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanju Yusuf","family":"Erdil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"2040_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","volume":"34","author":"M Theodoropoulou","year":"2013","unstructured":"Theodoropoulou M, Stalla GK. Somatostatin receptors: from signaling to clinical practice. Front Neuroendocrinol. 2013;34:228\u201352.","journal-title":"Front Neuroendocrinol"},{"key":"2040_CR2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1148\/rg.352140164","volume":"35","author":"MS Hofman","year":"2015","unstructured":"Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35:500\u201316.","journal-title":"Radiographics"},{"key":"2040_CR3","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","volume":"52","author":"TD Poeppel","year":"2011","unstructured":"Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, et al. 68Ga-DOTATOC versus 68Ga-DOTATATE PET\/CT in functional imaging of neuroendocrine tumors. J Nucl Med. 2011;52:1864\u201370.","journal-title":"J Nucl Med"},{"key":"2040_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/978-3-642-27994-2_18","volume":"194","author":"TD Poeppel","year":"2013","unstructured":"Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, et al. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET\/CT of gastroenteropancreatic neuroendocrine tumors. Recent Results Cancer Res. 2013;194:353\u201371.","journal-title":"Recent Results Cancer Res"},{"key":"2040_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ajcp\/102.6.752","volume":"102","author":"CL Moertel","year":"1994","unstructured":"Moertel CL, Reubi JC, Scheithauer BS, Schaid DJ, Kvols LK. Expression of somatostatin receptors in childhood neuroblastoma. Am J Clin Pathol. 1994;102:752\u20136.","journal-title":"Am J Clin Pathol"},{"key":"2040_CR6","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2967\/jnumed.116.186361","volume":"58","author":"L Bodei","year":"2017","unstructured":"Bodei L, Ambrosini V, Herrmann K, Modlin I. Current concepts in 68Ga-DOTATATE imaging of neuroendocrine neoplasms: interpretation, biodistribution, dosimetry, and molecular strategies. J Nucl Med. 2017;58:1718\u201326.","journal-title":"J Nucl Med"},{"key":"2040_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1053\/j.semnuclmed.2016.01.004","volume":"46","author":"P\u00d6 Kiratli","year":"2016","unstructured":"Kiratli P\u00d6, Tuncel M, Bar-Sever Z. Nuclear medicine in pediatric and adolescent tumors. Semin Nucl Med. 2016;46:308\u201323.","journal-title":"Semin Nucl Med"},{"key":"2040_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00247-020-04688-z","volume":"50","author":"KM McElroy","year":"2020","unstructured":"McElroy KM, Binkovitz LA, Trout AT, Czachowski MR, Seghers VJ, Lteif AN, et al. Pediatric applications of dotatate: early diagnostic and therapeutic experience. Pediatr Radiol. 2020;50:882\u201397.","journal-title":"Pediatr Radiol"},{"key":"2040_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29740","volume":"69","author":"AA Krokhmal","year":"2022","unstructured":"Krokhmal AA, Kwatra N, Drubach L, Weldon CB, Janeway KA, DuBois SG, et al. 68Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma. Pediatr Blood Cancer. 2022;69: e29740.","journal-title":"Pediatr Blood Cancer"},{"key":"2040_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/RLU.0b013e31825b2555","volume":"37","author":"J Kunikowska","year":"2012","unstructured":"Kunikowska J, Kr\u00f3licki L, Pawlak D, Zerizer I, Miko\u0142ajczak R. Semiquantitative analysis and characterization of physiological biodistribution of (68)Ga-DOTA-TATE PET\/CT. Clin Nucl Med. 2012;37:1052\u20137.","journal-title":"Clin Nucl Med"},{"key":"2040_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00259-004-1708-5","volume":"32","author":"F Jacobs","year":"2005","unstructured":"Jacobs F, Thierens H, Piepsz A, Bacher K, Van de Wiele C, Ham H, et al. Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. Eur J Nucl Med Mol Imaging. 2005;32:581\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2040_CR12","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1007\/s00259-015-3289-x","volume":"43","author":"JS Machado","year":"2016","unstructured":"Machado JS, Beykan S, Herrmann K, Lassmann M. Recommended administered activities for (68)Ga-labelled peptides in paediatric nuclear medicine. Eur J Nucl Med Mol Imaging. 2016;43:2036\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2040_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/jpm1010005","volume":"1","author":"P Gauthier","year":"2011","unstructured":"Gauthier P, Cardot JM. Developing drugs for children and the adjustment of medication-is it a new challenge or an adaptation of past ideas? J Pers Med. 2011;1:5\u201316.","journal-title":"J Pers Med"},{"key":"2040_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/RLU.0000000000001100","volume":"41","author":"F Moradi","year":"2016","unstructured":"Moradi F, Jamali M, Barkhodari A, Schneider B, Chin F, Quon A, et al. Spectrum of 68Ga-DOTA TATE uptake in patients with neuroendocrine tumors. Clin Nucl Med. 2016;41:281\u20137.","journal-title":"Clin Nucl Med"},{"key":"2040_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1385\/ENDO:20:3:265","volume":"20","author":"I Shimon","year":"2003","unstructured":"Shimon I. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs. Endocrine. 2003;20:265\u20139.","journal-title":"Endocrine"},{"key":"2040_CR16","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.3390\/cancers14122925","volume":"14","author":"P Palmisciano","year":"2022","unstructured":"Palmisciano P, Watanabe G, Conching A, Ogasawara C, Ferini G, Bin-Alamer O, et al. The role of [68Ga]Ga-DOTA-SSTR PET radiotracers in brain tumors: a systematic review of the literature and ongoing clinical trials. Cancers (Basel). 2022;14:2925.","journal-title":"Cancers (Basel)"},{"key":"2040_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/jcm8060763","volume":"8","author":"LK Anzola","year":"2019","unstructured":"Anzola LK, Rivera JN, Dierckx RA, Lauri C, Valabrega S, Galli F, et al. Value of somatostatin receptor scintigraphy with 99mTc-HYNIC-TOC in patients with primary sj\u00f6gren syndrome. J Clin Med. 2019;8:763.","journal-title":"J Clin Med"},{"key":"2040_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1046\/j.1365-2842.2002.00800.x","volume":"29","author":"LA de Oliveira","year":"2002","unstructured":"de Oliveira LA, de Oliveira VF, Gomez RS. Vascular endothelial growth factor in minor salivary glands: effect of ageing. J Oral Rehabil. 2002;29:105\u20137.","journal-title":"J Oral Rehabil"},{"key":"2040_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.regpep.2006.08.005","volume":"138","author":"M Druckenthaner","year":"2007","unstructured":"Druckenthaner M, Schwarzer C, Ensinger C, Gabriel M, Prommegger R, Riccabona G, et al. Evidence for somatostatin receptor 2 in thyroid tissue. Regul Pept. 2007;138:32\u20139.","journal-title":"Regul Pept"},{"key":"2040_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jamapediatrics.2016.0486","volume":"170","author":"P Hanley","year":"2016","unstructured":"Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: a review. JAMA Pediatr. 2016;170:1008\u201319.","journal-title":"JAMA Pediatr"},{"key":"2040_CR21","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1369\/jhc.2009.953919","volume":"57","author":"Z Varecza","year":"2009","unstructured":"Varecza Z, Elekes K, L\u00e1szl\u00f3 T, Perkecz A, Pint\u00e9r E, S\u00e1ndor Z, et al. Expression of the somatostatin receptor subtype 4 in intact and inflamed pulmonary tissues. J Histochem Cytochem. 2009;57:1127\u201337.","journal-title":"J Histochem Cytochem"},{"key":"2040_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s12350-022-03135-w","volume":"30","author":"P Kaushik","year":"2023","unstructured":"Kaushik P, Patel C, Chandra KB, Kumar S, Gupta P, Ojha V, et al. Semiquantitative evaluation of 68Ga-DOTANOC uptake in the normal myocardium: establishment of reference values. J Nucl Cardiol. 2023;30:1121\u20138.","journal-title":"J Nucl Cardiol"},{"key":"2040_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1677\/erc.0.0110323","volume":"11","author":"C Orlando","year":"2004","unstructured":"Orlando C, Raggi CC, Bianchi S, Distante V, Simi L, Vezzosi V, et al. Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue. Endocr Relat Cancer. 2004;11:323\u201332.","journal-title":"Endocr Relat Cancer"},{"key":"2040_CR24","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.dld.2003.11.020","volume":"36","author":"D Ferone","year":"2004","unstructured":"Ferone D, van Hagen PM, Semino C, Dalm VA, Barreca A, Colao A, et al. Somatostatin receptor distribution and function in immune system. Dig Liver Dis. 2004;36:S68\u201377.","journal-title":"Dig Liver Dis"},{"key":"2040_CR25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/BF03345797","volume":"35","author":"D Ferone","year":"2012","unstructured":"Ferone D, Pivonello R, Kwekkeboom DJ, Gatto F, Ameri P, Colao A, et al. Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: implications for the in vivo visualization during somatostatin receptor scintigraphy. J Endocrinol Invest. 2012;35:528\u201334.","journal-title":"J Endocrinol Invest"},{"key":"2040_CR26","doi-asserted-by":"publisher","first-page":"E791","DOI":"10.1152\/ajpendo.2000.279.4.E791","volume":"279","author":"D Ferone","year":"2000","unstructured":"Ferone D, Pivonello R, Van Hagen PM, Waaijers M, Zuijderwijk J, Colao A, et al. Age-related decrease of somatostatin receptor number in the normal human thymus. Am J Physiol Endocrinol Metab. 2000;279:E791\u20138.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2040_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1182\/blood.V92.1.191.413k12_191_197","volume":"92","author":"JC Reubi","year":"1998","unstructured":"Reubi JC, Horisberger U, Kappeler A, Laissue JA. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. Blood. 1998;92:191\u20137.","journal-title":"Blood"},{"key":"2040_CR28","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00259-011-1760-x","volume":"38","author":"C Boy","year":"2011","unstructured":"Boy C, Heusner TA, Poeppel TD, Redmann-Bischofs A, Unger N, Jentzen W, et al. 68Ga-DOTATOC PET\/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax. Eur J Nucl Med Mol Imaging. 2011;38:1224\u201336.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2040_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.036053","author":"H Reynaert","year":"2004","unstructured":"Reynaert H, Rombouts K, Vandermonde A, Urbain D, Kumar U, Bioulac-Sage P, et al. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut. 2004. https:\/\/doi.org\/10.1136\/gut.2003.036053.","journal-title":"Gut"},{"key":"2040_CR30","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3748\/wjg.v10.i11.1663","volume":"10","author":"SH Song","year":"2004","unstructured":"Song SH, Leng XS, Li T, Qin ZZ, Peng JR, Zhao L, et al. Expression of subtypes of somatostatin receptors in hepatic stellate cells. World J Gastroenterol. 2004;10:1663\u20135.","journal-title":"World J Gastroenterol"},{"key":"2040_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/RLU.0b013e3182393404","volume":"37","author":"Y Krausz","year":"2012","unstructured":"Krausz Y, Rubinstein R, Appelbaum L, Mishani E, Orevi M, Fraenkel M, et al. Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patterns. Clin Nucl Med. 2012;37:57\u201362.","journal-title":"Clin Nucl Med"},{"key":"2040_CR32","doi-asserted-by":"publisher","first-page":"14634","DOI":"10.1038\/srep14634","volume":"5","author":"C Ionescu-Tirgoviste","year":"2015","unstructured":"Ionescu-Tirgoviste C, Gagniuc PA, Gubceac E, Mardare L, Popescu I, Dima S, et al. A 3D map of the islet routes throughout the healthy human pancreas. Sci Rep. 2015;5:14634.","journal-title":"Sci Rep"},{"key":"2040_CR33","first-page":"1837","volume":"80","author":"J Epelbaum","year":"1995","unstructured":"Epelbaum J, Bertherat J, Prevost G, Kordon C, Meyerhof W, Wulfsen I, et al. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. J Clin Endocrinol Metab. 1995;80:1837\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"2040_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ecl.2024.01.001","volume":"53","author":"K Bangalore Krishna","year":"2024","unstructured":"Bangalore Krishna K, Witchel SF. Normal puberty. Endocrinol Metab Clin North Am. 2024;53:183\u201394.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2040_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0960-0760(93)90134-I","volume":"45","author":"G Aguilera","year":"1993","unstructured":"Aguilera G. Factors controlling steroid biosynthesis in the zona glomerulosa of the adrenal. J Steroid Biochem Mol Biol. 1993;45:147\u201351.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2040_CR36","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/gut.2004.042002","volume":"53","author":"M Gugger","year":"2004","unstructured":"Gugger M, Waser B, Kappeler A, Schonbrunn A, Reubi JC. Cellular detection of sst2A receptors in human gastrointestinal tissue. Gut. 2004;53:1431\u20136.","journal-title":"Gut"},{"key":"2040_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1749-6632.1994.tb17262.x","volume":"733","author":"JC Reubi","year":"1994","unstructured":"Reubi JC, Laissue J, Waser B, Horisberger U, Schaer JC. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues. Ann N Y Acad Sci. 1994;733:122\u201337.","journal-title":"Ann N Y Acad Sci"},{"key":"2040_CR38","first-page":"1323","volume":"77","author":"JC Reubi","year":"1993","unstructured":"Reubi JC, Horisberger U, Studer UE, Waser B, Laissue JA. Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta. J Clin Endocrinol Metab. 1993;77:1323\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2040_CR39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","volume":"27","author":"S Kuyumcu","year":"2013","unstructured":"Kuyumcu S, \u00d6zkan ZG, Sanli Y, Yilmaz E, Mudun A, Adalet I, et al. Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation. Ann Nucl Med. 2013;27:538\u201345.","journal-title":"Ann Nucl Med"},{"key":"2040_CR40","first-page":"181","volume":"26","author":"R Mazzucchelli","year":"2012","unstructured":"Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Di Primio R, Bono A, et al. Immunohistochemical expression and localization of somatostatin receptors in normal prostate, high grade prostatic intraepithelial neoplasia and prostate cancer and its many faces. J Biol Regul Homeost Agents. 2012;26:181\u201392.","journal-title":"J Biol Regul Homeost Agents"},{"key":"2040_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1365-2265.2002.01521.x","volume":"56","author":"VL Green","year":"2002","unstructured":"Green VL, Richmond I, Maguiness S, Robinson J, Helboe L, Adams IP, et al. Somatostatin receptor 2 expression in the human endometrium through the menstrual cycle. Clin Endocrinol (Oxf). 2002;56:609\u201314.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2040_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304813","volume":"19","author":"E Castillero","year":"2024","unstructured":"Castillero E, Camillo C, Erwin WC, Singh S, Mohamoud N, George I, et al. Somatostatin receptors in fibrotic myocardium. PLoS ONE. 2024;19: e0304813.","journal-title":"PLoS ONE"},{"key":"2040_CR43","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40618-022-01740-7","volume":"45","author":"E Vitali","year":"2022","unstructured":"Vitali E, Palagano E, Schiavone ML, Mantovani G, Sobacchi C, Mazziotti G, et al. Direct effects of octreotide on osteoblast cell proliferation and function. J Endocrinol Invest. 2022;45:1045\u201357.","journal-title":"J Endocrinol Invest"},{"key":"2040_CR44","first-page":"15","volume":"9","author":"T Otani","year":"2021","unstructured":"Otani T, Nakamoto Y, Ishimori T. Physiological FDG uptake in growth plate on pediatric PET. Asia Ocean J Nucl Med Biol. 2021;9:15\u201320.","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"2040_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ajmg.c.31357","volume":"163C","author":"PG Murray","year":"2013","unstructured":"Murray PG, Clayton PE. Endocrine control of growth. Am J Med Genet C Semin Med Genet. 2013;163C:76\u201385.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"2040_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4274\/mirt.galenos.2021.37268","volume":"30","author":"S \u00d6zg\u00fcven","year":"2021","unstructured":"\u00d6zg\u00fcven S, Filizo\u011flu N, Kesim S, \u00d6ks\u00fczo\u011flu K, \u015een F, \u00d6ne\u015f T, et al. Physiological biodistribution of 68Ga-DOTA-TATE in normal subjects. Mol Imaging Radionucl Ther. 2021;30(1):39\u201346.","journal-title":"Mol Imaging Radionucl Ther"},{"key":"2040_CR47","doi-asserted-by":"publisher","first-page":"708","DOI":"10.2967\/jnumed.115.163865","volume":"57","author":"SA Deppen","year":"2016","unstructured":"Deppen SA, Liu E, Blume JD, Clanton J, Shi C, Jones-Jackson LB, et al. Safety and efficacy of 68Ga-DOTATATE PET\/CT for diagnosis, staging, and treatment management of neuroendocrine tumors. J Nucl Med. 2016;57:708\u201314.","journal-title":"J Nucl Med"},{"key":"2040_CR48","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1007\/s00259-019-04455-9","volume":"46","author":"A Toriihara","year":"2019","unstructured":"Toriihara A, Baratto L, Nobashi T, Park S, Hatami N, Davidzon G, et al. Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET\/CT in patients with well-differentiated neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2019;46:2244\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2040_CR49","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2967\/jnumed.116.185587","volume":"58","author":"M Barrio","year":"2017","unstructured":"Barrio M, Czernin J, Fanti S, Ambrosini V, Binse I, Du L, et al. The impact of somatostatin receptor-directed PET\/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis. J Nucl Med. 2017;58:756\u201361.","journal-title":"J Nucl Med"},{"key":"2040_CR50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00004728-197906000-00001","volume":"3","author":"EJ Hoffman","year":"1979","unstructured":"Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr. 1979;3:299\u2013308.","journal-title":"J Comput Assist Tomogr"},{"key":"2040_CR51","first-page":"44","volume":"11","author":"H Marquis","year":"2023","unstructured":"Marquis H, Willowson KP, Bailey DL. Partial volume effect in SPECT & PET imaging and impact on radionuclide dosimetry estimates. Asia Ocean J Nucl Med Biol. 2023;11:44\u201354.","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"2040_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cpet.2007.10.005","volume":"2","author":"O Rousset","year":"2007","unstructured":"Rousset O, Rahmim A, Alavi A, Zaidi H. Partial volume correction strategies in PET. PET Clin. 2007;2:235\u201349.","journal-title":"PET Clin"},{"key":"2040_CR53","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00259-017-3775-4","volume":"44","author":"MCF Cysouw","year":"2017","unstructured":"Cysouw MCF, Kramer GM, Schoonmade LJ, Boellaard R, de Vet HCW, Hoekstra OS. Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2017;44:2105\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02040-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T13:03:22Z","timestamp":1750165402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02040-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02040-9","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}